Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer ; volume:14 ; number:1 ; day:16 ; month:1 ; year:2024 ; pages:1-7 ; date:12.2024
Scientific reports ; 14, Heft 1 (16.1.2024), 1-7, 12.2024
- Creator
-
Ikarashi, Daiki
Kitano, Shigehisa
Tsuyukubo, Takashi
Yamashita, Makiko
Matsuura, Tomohiko
Maekawa, Shigekatsu
Kato, Renpei
Kato, Yoichiro
Kanehira, Mitsugu
Takata, Ryo
Sugai, Tamotsu
Obara, Wataru
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-51273-7
- URN
-
urn:nbn:de:101:1-2024032721234649028249
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ikarashi, Daiki
- Kitano, Shigehisa
- Tsuyukubo, Takashi
- Yamashita, Makiko
- Matsuura, Tomohiko
- Maekawa, Shigekatsu
- Kato, Renpei
- Kato, Yoichiro
- Kanehira, Mitsugu
- Takata, Ryo
- Sugai, Tamotsu
- Obara, Wataru
- SpringerLink (Online service)
Other Objects (12)
Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
Pathological response and survival outcomes after neoadjuvant chemotherapy with radical cystectomy in octogenarians for muscle-invasive bladder cancer: an observational database study
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response
Evaluation of pathological response to neoadjuvant chemotherapy in locally advanced cervical cancer
MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
Survival outcomes of patients with muscle-invasive bladder cancer according to pathological response at radical cystectomy with or without neo-adjuvant chemotherapy: a case–control matching study
Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy
The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy
Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
Pathological response and survival outcomes after neoadjuvant chemotherapy with radical cystectomy in octogenarians for muscle-invasive bladder cancer: an observational database study
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response
Evaluation of pathological response to neoadjuvant chemotherapy in locally advanced cervical cancer
MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
Survival outcomes of patients with muscle-invasive bladder cancer according to pathological response at radical cystectomy with or without neo-adjuvant chemotherapy: a case–control matching study
Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy
The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy
Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
Pathological response and survival outcomes after neoadjuvant chemotherapy with radical cystectomy in octogenarians for muscle-invasive bladder cancer: an observational database study
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response
Evaluation of pathological response to neoadjuvant chemotherapy in locally advanced cervical cancer
MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
Survival outcomes of patients with muscle-invasive bladder cancer according to pathological response at radical cystectomy with or without neo-adjuvant chemotherapy: a case–control matching study
Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Whole-exome profiles of inflammatory breast cancer and pathological response to neoadjuvant chemotherapy